Document is current
Any future updates will be listed below
-
Authors
Nunez, Johanna
Holtz, Matilda
Korlakunta, Sneha https://orcid.org/0009-0008-7336-6579
Kang, Hanil https://orcid.org/0009-0005-3681-8642
Lin, Florence
Stowe, Hannah https://orcid.org/0000-0002-8698-0163
Pagani, Chase A.
Shah, Achira
Jeffery, Elise C.
Elhamad, Meriam
Nazemidashtarjandi, Saeed
Tower, Robert https://orcid.org/0000-0001-5856-5758
Choi, Ji Hae https://orcid.org/0009-0001-1408-3383
Kang, Heeseog https://orcid.org/0000-0002-2612-8585
Callan, Alexandra
Chen, Antonia F.
Ayata, Cenk https://orcid.org/0000-0002-3644-6042
Toner, Mehmet https://orcid.org/0000-0002-3647-3665
Levi, Benjamin
Karabacak, N. Murat https://orcid.org/0000-0003-2761-5593
-
Funding
Funding for this research was provided by:
Massachusetts General Hospital
Shriners Hospitals for Children
- License Information
-
More Information
Article History
Received: 17 May 2024
Accepted: 19 January 2026
First Online: 31 January 2026
Competing interests
: Massachusetts General Hospital has filed a patent application for the use of rare cell isolation technology in heterotopic ossification described in this publication (PCT Application No. PCT/US2024/055005). The remaining authors declare no competing interests.
